Loading...
XSHE002799
Market cap341mUSD
Jan 02, Last price  
7.78CNY
1D
2.64%
1Q
-2.02%
Jan 2017
-61.00%
IPO
54.98%
Name

XiAn Global Printing Co Ltd

Chart & Performance

D1W1MN
XSHE:002799 chart
P/E
—
P/S
1.56
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
5.29%
Rev. gr., 5y
23.59%
Revenues
1.60b
-46.04%
229,009,601258,343,343310,622,479332,347,790357,781,974359,970,362391,815,231400,003,693387,502,466438,211,497555,124,3321,247,341,5731,875,342,2232,936,304,7922,966,656,3801,600,910,936
Net income
-222m
L
18,974,07024,376,02032,062,76834,837,02538,005,93836,015,60938,142,26334,841,32826,795,98522,608,68728,112,26966,562,444101,292,165106,357,14486,591,122-221,928,603
CFO
135m
27,135,40041,988,40026,000,60063,837,00074,529,10055,008,27272,938,49563,098,08541,266,28151,911,95085,553,434139,913,3840117,613,5850134,527,227
Dividend
Aug 16, 20240.036 CNY/sh

Profile

Xi'an Global Printing Co., Ltd. provides packaging services to pharmaceutical producers in China and internationally. It offers pharmaceutical folding cartons, leaflets, pharmaceutical aluminum tubes, and other packaging products, as well as related package service plans. The company provides its products for OTC products, prescription medicines, health protection products, medical treatment articles, herbal medicines, and cosmetic products. Xi'an Global Printing Co., Ltd. was founded in 2001 and is based in Xi'an, China.
URL
https://www.globalprinting.cn/
IPO date
Jun 08, 2016
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,600,911
-46.04%
2,966,656
1.03%
Cost of revenue
1,418,352
2,797,061
Unusual Expense (Income)
NOPBT
182,559
169,595
NOPBT Margin
11.40%
5.72%
Operating Taxes
17,000
7,905
Tax Rate
9.31%
4.66%
NOPAT
165,558
161,690
Net income
(221,929)
-356.29%
86,591
-18.58%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
393,426
425,552
Long-term debt
3,919
22,629
Deferred revenue
15,652
9,500
Other long-term liabilities
Net debt
(274,652)
(578,558)
Cash flow
Cash from operating activities
134,527
CAPEX
(301,906)
Cash from investing activities
(308,692)
Cash from financing activities
(177,129)
735,354
FCF
62,084
(216,399)
Balance
Cash
567,445
906,522
Long term investments
104,552
120,217
Excess cash
591,951
878,406
Stockholders' equity
616,984
971,774
Invested Capital
1,195,456
1,256,109
ROIC
13.51%
15.11%
ROCE
10.21%
7.94%
EV
Common stock shares outstanding
321,636
320,040
Price
11.94
-17.83%
14.53
19.88%
Market cap
3,840,330
-17.42%
4,650,181
52.25%
EV
3,587,791
4,170,347
EBITDA
214,204
200,590
EV/EBITDA
16.75
20.79
Interest
14,852
18,850
Interest/NOPBT
8.14%
11.11%